Vitreoretinal Surgery Device Market

Vitreoretinal Surgery Device Market Outlook (2024 to 2034)

According to a new industry report released by Fact.MR, revenue from the global vitreoretinal surgery device market size is estimated at US$ 2.23 billion in 2024 and is evaluated to increase at a CAGR of 6.1% from 2024 to 2034. Demand for vitreoretinal surgery devices is projected to reach a market value of US$ 4.01 billion by the end of 2034.

Vitreoretinal surgical devices are tools used primarily in vitreoretinal operations to treat conditions affecting the macula, retina, and other eye areas. Advancements in vitreoretinal surgical devices are significantly enhancing surgical precision, safety, and outcomes. These include advanced vitrectomy machines, high-resolution imaging systems, microincision vitrectomy surgery (MIVS) techniques, and state-of-the-art laser technologies, providing surgeons with superior tools for performing intricate treatments, thereby driving market expansion.

Development of new technologies and strong partnerships among academic institutions, medical device manufacturers, and healthcare providers are fostering innovation in vitreoretinal surgery. These collaborations enable the pooling of resources and expertise to develop surgical instruments that are more advanced and efficacious for the market.

Vitreoretinal surgical devices are commonly used to treat various eye problems such as diabetic retinopathy, macular degeneration, and retinal tears. Increasing incidence of diabetic retinopathy among the elderly is contributing to the expansion of the vitreoretinal surgery device market size.

Key Market Growth Drivers

• Primary factor that is driving market growth is the increasing prevalence of various eye-related conditions worldwide.
• Government programs and measures that raise awareness of various eye illnesses and the advantages of using vitreoretinal implants for treatment are projected to benefit market players.
• Increasing number of cases of eye diseases among the geriatric population is projected to contribute to market expansion in the coming years.
• Expanding trend in the vitreoretinal surgery device market is continuous innovation aimed at enhancing user-friendliness and automation, thereby boosting adoption rates.
• The vitrectomy probes segment is expected to make a significant contribution to the market, thanks to their improved capability to remove shear collagen fibers without the need for 3D surgery.
• Global demand for minimally invasive surgeries is on the rise, which is fueling the adoption of vitreoretinal surgery devices.

Report Attribute	Detail
Vitreoretinal Surgery Device Market Size (2024E)	US$ 2.23 Billion
Forecasted Market Value (2034F)	US$ 4.01 Billion
Global Market Growth Rate (2024 to 2034)	6.1% CAGR
North America Market Share (2024E)	32.1%
East Asia Market Value (2024E)	US$ 438 Million
Sales of Vitrectomy Accessories (2034F)	US$ 1.53 Billion
Retinal Detachment Segment Value (2034F)	US$ 1.86 Billion
Key Companies Profiled	Hoya Surgical Optics; Rodenstock; Topcon Corporation; Alcon Inc.; Cooper Vision; British Virgin Islands (BVI); Johnson & Johnson Vision Care, Inc.; Erbe Elektromedizin; Safilo Group; Carl Zeiss Meditec AG; Blink Medical; Nidek Co., Ltd.

What’s Creating Profitable Opportunities for Vitreoretinal Surgery Device Manufacturers?

“Advancements in Vitreoretinal Surgery Devices and Focus on Reduced Invasiveness”

Advancements in vitreoretinal surgery devices are enhancing the precision, safety, and outcomes of these complex procedures. The latest innovations in vitreoretinal surgery are aimed at improving the efficiency and effectiveness of surgical interventions, while high-resolution imaging devices offer a clearer view of retinal structures. Techniques like microincision vitrectomy surgery (MIVS) reduce the invasiveness of procedures, promoting quicker patient recovery with fewer complications.

Modern laser technologies further enable precise tissue targeting and therapy. These technological advancements provide surgeons with enhanced tools, improving surgical success rates and patient outcomes, thereby contributing to market growth.

What is a Roadblock for Vitreoretinal Surgery Device Manufacturers?

“High Cost and Technical Complexity of Vitreoretinal Surgery Devices”

Complexity and technical challenges inherent in vitreoretinal procedures deter demand, requiring exceptional skills and precision from professionals who must undergo specialized training and gain expertise for successful execution. Errors during surgery pose significant risks and necessitate a high level of proficiency due to their potentially catastrophic consequences. These factors discourage many professionals from investing in vitreoretinal surgery devices and integrating them into their practice.

High cost of vitreoretinal surgery devices contributes to the dampened demand. These technologies are prohibitively expensive for healthcare facilities with limited budgets or low-income settings. Patients also bear a substantial financial burden, covering expenses such as operating room fees, device costs, and postoperative care associated with vitreoretinal surgical treatments. All of these elements are restricting vitreoretinal surgery device market growth.

Country-wise Insights

In 2024, North America is estimated to lead with 32.1% of the global vitreoretinal surgery device market share. The East Asia market is evaluated to expand at a significant CAGR of 7.9% from 2024 to 2034.

What is Pushing Demand for Vitreoretinal Surgery Devices in the United States?

“Adoption of Advanced Laser Technology and Sophisticated Vitrectomy Equipment”

Attribute	United States
Market Value (2024E)	US$ 604 Million
Growth Rate (2024 to 2034)	4.2% CAGR
Projected Value (2034F)	US$ 916 Million

When it comes to developments in healthcare technology, particularly in vitreoretinal surgical devices, the United States stands out globally. Innovations such as advanced laser technology, sophisticated vitrectomy equipment, and high-resolution imaging systems are revolutionizing the accuracy and outcomes of retinal procedures in the country. These are key vitreoretinal surgery device market trends that manufacturers in the country are leveraging to enhance their profit margins. Medical professionals are embracing these cutting-edge technologies for their ability to enhance the precision and effectiveness of treatments.

Will High Prevalence of Diabetes Boost Demand for Vitreoretinal Surgical Devices in Japan?

“Rising Cases of Diabetes-Related Retinopathy Necessitating Advanced Surgical Interventions”

Attribute	Japan
Market Value (2024E)	US$ 114 Million
Growth Rate (2024 to 2034)	7.3% CAGR
Projected Value (2034F)	US$ 231 Million

Diabetes-related retinopathy, a serious eye condition, is increasingly prevalent in Japan due to the rising number of diabetes cases, posing a significant health challenge. Treatment typically involves vitreoretinal surgery, driving demand for vitreoretinal surgical devices in the country. Advanced surgical interventions are increasingly vital for effectively managing the growing diabetic population and associated complications like retinopathy. The importance of vitreoretinal surgical devices in addressing diabetic eye issues and elevating the overall standard of eye care in Japan is paramount.

Category-wise Insights

Based on end user, the market is segmented into hospitals, eye clinics, and ASCs. Hospitals are poised to account for a significant market share of 43.8% in 2024.

Which Type of Vitreoretinal Surgery Device is Most Widely Used?

“Rising Incidence of Retinal Detachment Driving Use of Vitrectomy Accessories”

Attribute	Vitrectomy Accessories
Segment Value (2024E)	US$ 862.3 Million
Growth Rate (2024 to 2034)	5.9% CAGR
Projected Value (2034F)	US$ 1.53 Billion

By product type, the market is divided into vitrectomy accessories, vitrectomy packs, vitrectomy machines, and disposables. Vitrectomy accessories are set to hold 38.8% market share in 2024. Demand for vitrectomy accessories is growing at a steady pace due to the increasing prevalence of retinal detachment.

Why are Vitreoretinal Surgery Devices Becoming Essential in Managing Retinal Detachment?

“Vitreoretinal Surgery Devices Offering Improved Treatment Outcomes for Retinal Detachment”

Attribute	Retinal Detachment
Segment Value (2024E)	US$ 950.7 Million
Growth Rate (2024 to 2034)	7% CAGR
Projected Value (2034F)	US$ 1.86 Billion

As technology and surgical techniques advance, the utilization of vitreoretinal surgery devices in treating retinal detachment is on the rise. These technologies enable more precise and minimally invasive procedures, leading to improved outcomes and faster recovery periods for patients. Surgeons can now effectively manage a range of retinal issues, including complex cases that were once challenging to treat. As a result, vitreoretinal surgery instruments are becoming increasingly crucial in the treatment of retinal detachment and related disorders.

Competitive Landscape

Key players in the vitreoretinal surgery device market are focusing on launching innovative techniques to treat retinal detachments, as well as increasing the scope of application of vitrectomy in this regard. Nonetheless, the technological benefits of these products rank among the main differentiators.

• In December 2023, to increase the range of ophthalmic devices it offers, Carl Zeiss Meditec agreed to acquire the Dutch Ophthalmic Research Center. With the purchase, Zeiss intends to increase the range of vitreoretinal surgical instruments in its inventory. The transaction is expected to be completed in 2024, with a valuation of around US$ 1.07 billion.
• In June 2022, to give surgeons a more accurate and effective approach to executing vitreoretinal surgical treatments, Ellex Medical Lasers announced the debut of its new minimally invasive technology, the EYESYS 23G Vitrectomy technology.
• In May 2022, Constellation Vision System, a new generation of vitreoretinal surgical platforms from Alcon, was introduced. It offers several technical advancements, including better visualization and more accurate instrumentation.

Fact.MR provides detailed information about the price points of key manufacturers of vitreoretinal surgery devices positioned across the world, sales growth, production capacity, and speculative technological expansion, in this new market report.

Segmentation of Vitreoretinal Surgery Device Market Research

• By Product Type :

  • Vitrectomy Accessories
  • Vitrectomy Packs
  • Vitrectomy Machines
  • Disposables

• By Application :

  • Diabetic Vitreous Hemorrhage
  • Retinal Detachment
  • Macular Hole

• By End User :

  • Hospitals
  • Eye Clinics
  • ASCs

• By Region :

  • North America
  • Western Europe
  • Eastern Europe
  • Latin America
  • East Asia
  • South Asia & Pacific
  • Middle East & Africa